Search Results

5176 - 5200 of 109805
TitleWireDateTime
Functional Protein Market projected to Top $7.2 Billion by 2031: Coherent Market Insights, Inc Globe Newswire 06/11 15:25
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Marinus Pharmaceuticals, Inc. Globe Newswire 06/11 15:18
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids Globe Newswire 06/11 15:05
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectives Globe Newswire 06/11 15:03
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil Globe Newswire 06/11 15:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) Globe Newswire 06/11 15:00
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now Globe Newswire 06/11 15:00
PyroGenesis Signs Contracts Totaling $2.5 Million to Deliver Greenhouse Gas-Reducing System for Major North American Biofuel Project Globe Newswire 06/11 15:00
Losing Talent in the Age of AI: Global Survey Finds Businesses Fail to Unlock the Full Potential of their Employees Globe Newswire 06/11 15:00
Solaris Reports 81m of 0.73% CuEq within 544m of 0.50% CuEq from Surface; Announces Major Expansion of 2024 Drill Program Supported by Record Productivity Globe Newswire 06/11 15:00
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split Globe Newswire 06/11 15:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2024 Globe Newswire 06/11 15:00
NFI subsidiary Alexander Dennis announces contract with Reading Buses for 53 buses including next-generation Enviro400EV electrics Globe Newswire 06/11 15:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS) Globe Newswire 06/11 15:00
Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH Globe Newswire 06/11 15:00
Applied Optoelectronics Set to Join Russell 3000® Index Globe Newswire 06/11 15:00
ZeroFox Named Winner of the Global InfoSec Awards and Cybersecurity Excellence Awards Globe Newswire 06/11 15:00
Kaltura Announces Stock Repurchase Program Globe Newswire 06/11 15:00
Red Cat Signs LOI To Acquire FlightWave Aerospace Systems Globe Newswire 06/11 15:00
YieldMax™ Launches Option Income Strategy ETF on Snowflake (SNOW) Globe Newswire 06/11 14:55
Descartes’ Study Shows 40% of Shippers and Logistics Services Providers Plan to Invest in Transportation Technology to Address Industry Changes Globe Newswire 06/11 14:45
BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminded to Contact BFA Law Before Approaching July 2024 Legal Deadline Globe Newswire 06/11 14:43
SPROUT SOCIAL NOTICE: If You Suffered Losses on Your Sprout Social (Nasdaq: SPT) Investment, You are Reminded to Contact BFA Law Before Approaching July 2024 Legal Deadline Globe Newswire 06/11 14:36
Park Hotels & Resorts Announces Second Quarter 2024 Earnings Conference Call on August 1, 2024 Globe Newswire 06/11 14:30
Fastly ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Investors to Contact the Firm to Learn More Globe Newswire 06/11 14:30
5176 - 5200 of 109805

News, Photo and Web Search